TAILIEUCHUNG - Ebook Management of atrial fibrillation: Part 2

Part 2 book “Management of atrial fibrillation” has contents: Use of antiarrhythmic drug treatment in atrial fibrillation, anticoagulation selection and stroke prevention, when to refer patients for non-pharmacological therapies, summary guidelines for the management of atrial fibrillation. | Chapter 5 Use of antiarrhythmic drug treatment in atrial fibrillation Irene Savelieva and A. John Camm Key points • Despite several trials demonstrating non-inferiority of rate control to rhythm control, with some advantages to the former, rhythm control is the preferred treatment strategy in young and active individuals and those who remain symptomatic despite best possible rate control; nevertheless, rate control is relevant to all forms of AF and to all patients with AF. • The choice of an antiarrhythmic drug should be driven by its safety (preferably the effect on hard endpoints such as mortality if available) which, in turn, is determined by the underlying cardiovascular disease and other individual patient characteristics (. co-morbidities and concomitant medication). • Dronedarone can be used safely in patients with non-permanent atrial fibrillation provided they do not have unstable or advanced heart failure; the drug is better avoided or should be used with caution in individuals with milder forms of heart failure unless there is no alternative • Regular electrocardiogram monitoring as well as biochemistry and functional tests (specific for each drug) are mandatory. • In selected patients, short-term use of antiarrhythmic drugs after cardioversion or a ‘pill-in-the-pocket’ strategy can be used in order to minimize the adverse effects. 5.   Principles of therapy The main principles of atrial fibrillation (AF) management consist of risk assessment for stroke and appropriate antithrombotic prophylaxis, usually in the form of oral anticoagulation; rhythm control therapy aimed at prevention of recurrent paroxysmal or persistent AF which may include antiarrhythmic drugs, catheter ablation, and cardioversion of arrhythmia which fails to self-terminate; control of ventricular rates during recurrent or permanent AF; and treatment of the conditions that are commonly associated with the occurrence and perpetuation of AF (Camm et al. 20 0). The nature of AF and .

• Y khoa - Dược
• Management of atrial fibrillation
• Atrial fibrillation
• Anticoagulation selection
• Stroke prevention
• Non pharmacological therapies
• Summary guidelines
• The epidemiology of atrial fibrillation
• Clinical subsets
• Atrial fibrillation fist presents
• A multidisciplinary approach to improving patient outcomes
• Epidemiology of atrial fibrillation
• The atrial fibrillation patient
• Nonpharmacologic approaches
• Rhythm management
• Left atrial appendage closure
• Mechanical approaches to stroke prevention
• Percutaneous LAA closure devices
• Post procedural management and issues
• Management of patients who require oral anticoagulation
• Post PCI antiplatelet therapy
• OAC plus DAPT
• Pre PCI Considerations
• trình bày báo cáo
• tài liệu báo cáo khoa học
• báo cáo y học
• công trình y học
• kiến thức ngành y
• previous infection
• spreads via
• matting and fixation
• fascia and present
• sinus formation
• gingiva or conjunctiva
• BMC Anesthesiology
• Laryngeal mask
• Catheter ablation
• Radiofrequency catheter ablation
• Machinery and equipment
• Equipment items
• Summary of pilot study
• Working methods
• Pricing guidelines
• The product list
• GAP
• FAO
• agricutural codes
• agricutural guidelines
• agricutural standards
• Management Commitment
• Risk Assessment
• Freight Forwarder Guidance
• Screenings and Addressing Vulnerabilities
• Problems and Violations
• Compliance Guidelines Summary
• Summary of doctoral dissertation
• Wave Sea dikes with crown walls
• The northern coastal delta of Vietnam
• The dike design guidelines currently
• Crown walls in the north
• công trình nghiên cứu y học
• kiến thức y học
• technical summary
• Coronary Interventions
• Vascular Access
• Percutaneous Coronary
• Coronary Intervention
• Cardiac Arrest Survivors